Characterization of autotransplant-related thrombocytopenia by evaluation of glycocalicin and reticulated platelets

L. Catani, N. Vianelli, S. Luatti, S. Rizzi, S. Castellani, L. Valdrè, R. M. Lemoli, S. Tura

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Thrombocytopoiesis of 21 multiple myeloma patients undergoing single or double transplant regimen was characterized by measuring the level of reticulated platelets and plasma glycocalicin. Since reticulated platelets are an index of thrombopoietic activity and glycocalicin plasma values are related to platelet damage and turnover, it may be possible to perform a novel type of analysis of the thrombopoietic compartment during the mobilizing regimen and during transplant-related chemotherapy. Patients underwent mobilizing therapy and first transplant. Some randomized patients also underwent a second transplant with mobilized peripheral blood stem cells. The results show that the percentage of reticulated platelets decreased after therapy and then gradually increased in the recovery phase either during first or second transplant. By contrast, the percentage of reticulated platelets increased until day +8 and then gradually decreased during the mobilizing regimen. The glycocalicin index (glycocalicin plasma value normalized for the individual platelet count) increased significantly both during the course of mobilization and after transplant-related chemotherapy when the platelet number was at its nadir. However, the glycocalicin index was more elevated after transplant-related chemotherapy than after the mobilizing regimen. Our findings suggest that chemotherapy-related thrombocytopenia may be due to a dual mechanism: thrombocytopenia results from decreased platelet production in addition to increased platelet damage and possible destruction.

Original languageEnglish
Pages (from-to)1191-1194
Number of pages4
JournalBone Marrow Transplantation
Volume24
Issue number11
Publication statusPublished - 1999

Fingerprint

Autografts
Thrombocytopenia
Blood Platelets
Transplants
Drug Therapy
Platelet Count
Thrombopoiesis
glycocalicin
Multiple Myeloma
Therapeutics

Keywords

  • Glycocalicin
  • Reticulated platelets
  • Thrombocytopenia after transplant

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

Catani, L., Vianelli, N., Luatti, S., Rizzi, S., Castellani, S., Valdrè, L., ... Tura, S. (1999). Characterization of autotransplant-related thrombocytopenia by evaluation of glycocalicin and reticulated platelets. Bone Marrow Transplantation, 24(11), 1191-1194.

Characterization of autotransplant-related thrombocytopenia by evaluation of glycocalicin and reticulated platelets. / Catani, L.; Vianelli, N.; Luatti, S.; Rizzi, S.; Castellani, S.; Valdrè, L.; Lemoli, R. M.; Tura, S.

In: Bone Marrow Transplantation, Vol. 24, No. 11, 1999, p. 1191-1194.

Research output: Contribution to journalArticle

Catani, L, Vianelli, N, Luatti, S, Rizzi, S, Castellani, S, Valdrè, L, Lemoli, RM & Tura, S 1999, 'Characterization of autotransplant-related thrombocytopenia by evaluation of glycocalicin and reticulated platelets', Bone Marrow Transplantation, vol. 24, no. 11, pp. 1191-1194.
Catani L, Vianelli N, Luatti S, Rizzi S, Castellani S, Valdrè L et al. Characterization of autotransplant-related thrombocytopenia by evaluation of glycocalicin and reticulated platelets. Bone Marrow Transplantation. 1999;24(11):1191-1194.
Catani, L. ; Vianelli, N. ; Luatti, S. ; Rizzi, S. ; Castellani, S. ; Valdrè, L. ; Lemoli, R. M. ; Tura, S. / Characterization of autotransplant-related thrombocytopenia by evaluation of glycocalicin and reticulated platelets. In: Bone Marrow Transplantation. 1999 ; Vol. 24, No. 11. pp. 1191-1194.
@article{3e3a4a1d42e64d929f84f87d1602e9c2,
title = "Characterization of autotransplant-related thrombocytopenia by evaluation of glycocalicin and reticulated platelets",
abstract = "Thrombocytopoiesis of 21 multiple myeloma patients undergoing single or double transplant regimen was characterized by measuring the level of reticulated platelets and plasma glycocalicin. Since reticulated platelets are an index of thrombopoietic activity and glycocalicin plasma values are related to platelet damage and turnover, it may be possible to perform a novel type of analysis of the thrombopoietic compartment during the mobilizing regimen and during transplant-related chemotherapy. Patients underwent mobilizing therapy and first transplant. Some randomized patients also underwent a second transplant with mobilized peripheral blood stem cells. The results show that the percentage of reticulated platelets decreased after therapy and then gradually increased in the recovery phase either during first or second transplant. By contrast, the percentage of reticulated platelets increased until day +8 and then gradually decreased during the mobilizing regimen. The glycocalicin index (glycocalicin plasma value normalized for the individual platelet count) increased significantly both during the course of mobilization and after transplant-related chemotherapy when the platelet number was at its nadir. However, the glycocalicin index was more elevated after transplant-related chemotherapy than after the mobilizing regimen. Our findings suggest that chemotherapy-related thrombocytopenia may be due to a dual mechanism: thrombocytopenia results from decreased platelet production in addition to increased platelet damage and possible destruction.",
keywords = "Glycocalicin, Reticulated platelets, Thrombocytopenia after transplant",
author = "L. Catani and N. Vianelli and S. Luatti and S. Rizzi and S. Castellani and L. Valdr{\`e} and Lemoli, {R. M.} and S. Tura",
year = "1999",
language = "English",
volume = "24",
pages = "1191--1194",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Characterization of autotransplant-related thrombocytopenia by evaluation of glycocalicin and reticulated platelets

AU - Catani, L.

AU - Vianelli, N.

AU - Luatti, S.

AU - Rizzi, S.

AU - Castellani, S.

AU - Valdrè, L.

AU - Lemoli, R. M.

AU - Tura, S.

PY - 1999

Y1 - 1999

N2 - Thrombocytopoiesis of 21 multiple myeloma patients undergoing single or double transplant regimen was characterized by measuring the level of reticulated platelets and plasma glycocalicin. Since reticulated platelets are an index of thrombopoietic activity and glycocalicin plasma values are related to platelet damage and turnover, it may be possible to perform a novel type of analysis of the thrombopoietic compartment during the mobilizing regimen and during transplant-related chemotherapy. Patients underwent mobilizing therapy and first transplant. Some randomized patients also underwent a second transplant with mobilized peripheral blood stem cells. The results show that the percentage of reticulated platelets decreased after therapy and then gradually increased in the recovery phase either during first or second transplant. By contrast, the percentage of reticulated platelets increased until day +8 and then gradually decreased during the mobilizing regimen. The glycocalicin index (glycocalicin plasma value normalized for the individual platelet count) increased significantly both during the course of mobilization and after transplant-related chemotherapy when the platelet number was at its nadir. However, the glycocalicin index was more elevated after transplant-related chemotherapy than after the mobilizing regimen. Our findings suggest that chemotherapy-related thrombocytopenia may be due to a dual mechanism: thrombocytopenia results from decreased platelet production in addition to increased platelet damage and possible destruction.

AB - Thrombocytopoiesis of 21 multiple myeloma patients undergoing single or double transplant regimen was characterized by measuring the level of reticulated platelets and plasma glycocalicin. Since reticulated platelets are an index of thrombopoietic activity and glycocalicin plasma values are related to platelet damage and turnover, it may be possible to perform a novel type of analysis of the thrombopoietic compartment during the mobilizing regimen and during transplant-related chemotherapy. Patients underwent mobilizing therapy and first transplant. Some randomized patients also underwent a second transplant with mobilized peripheral blood stem cells. The results show that the percentage of reticulated platelets decreased after therapy and then gradually increased in the recovery phase either during first or second transplant. By contrast, the percentage of reticulated platelets increased until day +8 and then gradually decreased during the mobilizing regimen. The glycocalicin index (glycocalicin plasma value normalized for the individual platelet count) increased significantly both during the course of mobilization and after transplant-related chemotherapy when the platelet number was at its nadir. However, the glycocalicin index was more elevated after transplant-related chemotherapy than after the mobilizing regimen. Our findings suggest that chemotherapy-related thrombocytopenia may be due to a dual mechanism: thrombocytopenia results from decreased platelet production in addition to increased platelet damage and possible destruction.

KW - Glycocalicin

KW - Reticulated platelets

KW - Thrombocytopenia after transplant

UR - http://www.scopus.com/inward/record.url?scp=0033376583&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033376583&partnerID=8YFLogxK

M3 - Article

C2 - 10642807

AN - SCOPUS:0033376583

VL - 24

SP - 1191

EP - 1194

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

IS - 11

ER -